New Jersey Regulatory Submission Specialist
Exam Question and correct
answers (verified answers 100%) Q&A
2026/2027 INSTANT DOWNLOAD PDF
1. What is the primary purpose of a regulatory submission?
A. To market a product immediately
B. To obtain regulatory authority approval for a product
C. To increase company profits
D. To recruit clinical trial participants
Rationale: Regulatory submissions provide evidence of safety, efficacy, and quality
to obtain approval from regulatory authorities.
2. Which U.S. agency reviews most pharmaceutical regulatory submissions?
A. CDC
B. NIH
C. FDA
D. OSHA
Rationale: The Food and Drug Administration (FDA) is responsible for evaluating
pharmaceutical submissions in the United States.
3. What does IND stand for?
1
,A. Investigational New Drug
B. International New Device
C. Internal New Development
D. Investigational Novel Data
Rationale: An IND application allows clinical studies of an investigational drug to
begin.
4. Which section of a submission contains clinical study results?
A. Module 1
B. Module 2
C. Module 5
D. Module 3
Rationale: Module 5 of the CTD contains clinical study reports and supporting
clinical data.
5. What is the purpose of the Common Technical Document (CTD)?
A. Financial reporting
B. Standardized regulatory submission format
C. Marketing strategy planning
D. Employee training
Rationale: CTD provides a harmonized structure for regulatory submissions across
regions.
6. Which CTD module contains quality information?
A. Module 3
B. Module 1
2
, C. Module 4
D. Module 5
Rationale: Module 3 contains chemistry, manufacturing, and controls (CMC)
information.
7. What is an NDA?
A. New Device Authorization
B. National Drug Approval
C. New Drug Application
D. Novel Data Assessment
Rationale: An NDA is submitted to seek approval for marketing a new drug in the
U.S.
8. Which document summarizes the overall quality, nonclinical, and clinical
data?
A. Investigator Brochure
B. Module 2 Summaries
C. Protocol
D. Labeling Guide
Rationale: Module 2 provides high-level summaries of the complete submission.
9. What does eCTD stand for?
A. Electronic Common Technical Document
B. Enhanced Clinical Trial Data
C. Electronic Clinical Trial Documentation
D. Expanded CTD
Rationale: eCTD is the electronic format used for regulatory submissions.
3
Exam Question and correct
answers (verified answers 100%) Q&A
2026/2027 INSTANT DOWNLOAD PDF
1. What is the primary purpose of a regulatory submission?
A. To market a product immediately
B. To obtain regulatory authority approval for a product
C. To increase company profits
D. To recruit clinical trial participants
Rationale: Regulatory submissions provide evidence of safety, efficacy, and quality
to obtain approval from regulatory authorities.
2. Which U.S. agency reviews most pharmaceutical regulatory submissions?
A. CDC
B. NIH
C. FDA
D. OSHA
Rationale: The Food and Drug Administration (FDA) is responsible for evaluating
pharmaceutical submissions in the United States.
3. What does IND stand for?
1
,A. Investigational New Drug
B. International New Device
C. Internal New Development
D. Investigational Novel Data
Rationale: An IND application allows clinical studies of an investigational drug to
begin.
4. Which section of a submission contains clinical study results?
A. Module 1
B. Module 2
C. Module 5
D. Module 3
Rationale: Module 5 of the CTD contains clinical study reports and supporting
clinical data.
5. What is the purpose of the Common Technical Document (CTD)?
A. Financial reporting
B. Standardized regulatory submission format
C. Marketing strategy planning
D. Employee training
Rationale: CTD provides a harmonized structure for regulatory submissions across
regions.
6. Which CTD module contains quality information?
A. Module 3
B. Module 1
2
, C. Module 4
D. Module 5
Rationale: Module 3 contains chemistry, manufacturing, and controls (CMC)
information.
7. What is an NDA?
A. New Device Authorization
B. National Drug Approval
C. New Drug Application
D. Novel Data Assessment
Rationale: An NDA is submitted to seek approval for marketing a new drug in the
U.S.
8. Which document summarizes the overall quality, nonclinical, and clinical
data?
A. Investigator Brochure
B. Module 2 Summaries
C. Protocol
D. Labeling Guide
Rationale: Module 2 provides high-level summaries of the complete submission.
9. What does eCTD stand for?
A. Electronic Common Technical Document
B. Enhanced Clinical Trial Data
C. Electronic Clinical Trial Documentation
D. Expanded CTD
Rationale: eCTD is the electronic format used for regulatory submissions.
3
